Seraph group Revenue and Competitors

Location

N/A

Total Funding

VC/PE

Industry

Estimated Revenue & Valuation

  • Seraph group's estimated annual revenue is currently $15M per year.(i)
  • Seraph group's estimated revenue per employee is $789,474

Employee Data

  • Seraph group has 19 Employees.(i)
  • Seraph group grew their employee count by -10% last year.

Seraph group's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Financial Officer (Venture Capital)Reveal Email/Phone
3
Director OperationsReveal Email/Phone
4
PartnerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.5M225%$78.9MN/A
#2
$35M16N/AN/AN/A
#3
$3.5M120%N/AN/A
#4
N/A31-11%N/AN/A
#5
$3.5M5841%N/AN/A
#6
$7.5M6-40%N/AN/A
#7
N/A28-18%N/AN/A
#8
N/A100%N/AN/A
#9
$7.5M7-12%N/AN/A
#10
$1.7M560%N/AN/A
Add Company

What Is Seraph group?

Seraph Group is an early-stage venture firm that offers investors a diversified portfolio of technology startups, and entrepreneurs between $100K to $2M in seed and early stage capital. Seraph Group brings together successful individuals who share a passion for investing in technology startups. Opportunists join Seraph for a managed and curated portfolio of 20+ companies, for the ability to coinvest on a deal-by-deal basis, and for the opportunity to work with entrepreneurs.

keywords:N/A

N/A

Total Funding

19

Number of Employees

$15M

Revenue (est)

-10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Seraph group News

2022-04-20 - medIQ eyes wider outreach after raising $1.8 million

It is the first direct investment for both Amaana Capital and Seraph Group in a Pakistani startup. medIQ is Pakistan's first integrated B2B...

2022-04-19 - Seraph Brass Quintet Set to Perform at Bankhead Theater

Winner of the 2019 American Prize in Chamber Music, Seraph Brass is a dynamic group drawing from a roster of America's top women players who...

2022-04-17 - Results Published for Seraph 100 Treatment of COVID-19 ...

Mortality was lower in the Seraph 100 treated group compared to controls in both univariate and multivariate analyses: 32.1% vs.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.8M19-14%N/A
#2
N/A190%N/A
#3
$2.1M19-5%N/A
#4
$1.7M19N/AN/A
#5
$1.7M19N/AN/A